SIK2 and ovarian cancer: Findings from a recent study that we conducted showed that SIK2 is required for centrosome splitting in the mitosis of ovarian cancer cells [8] and that ARN‐3236 inhibited SIK2 and sensitized ovarian cancer cells to paclitaxel [9].